Gene · 7334
Papers2,223
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,223
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deubiquitinase OTUD6A Regulates Innate Immune Response via Targeting UBC13. | Viruses | 2023 | 37632103 | PubTator, text mining | PubMed |
| Interplay of Impaired Cellular Bioenergetics and Autophagy in PMM2-CDG. | Genes (Basel) | 2023 | 37628636 | PubTator, text mining | PubMed |
| TRIM5 Promotes Systemic Lupus Erythematosus Through CD4(+) T Cells and Macrophage. | Int J Gen Med | 2023 | 37614552 | PubTator, text mining | PubMed |
| The dynamic process of covalent and non-covalent PARylation in the maintenance of genome integrity: a focus on PARP inhibitors. | NAR Cancer | 2023 | 37609662 | PubTator, text mining | PubMed |
| The identification of genes associated T-cell exhaustion and construction of prognostic signature to predict immunotherapy response in lung adenocarcinoma. | Sci Rep | 2023 | 37592010 | PubTator, text mining | PubMed |
| Potential immunosuppressive clonal hematopoietic mutations in tumor infiltrating immune cells in breast invasive carcinoma. | Sci Rep | 2023 | 37573441 | PubTator, text mining | PubMed |
| Auranofin targets UBA1 and enhances UBA1 activity by facilitating ubiquitin trans-thioesterification to E2 ubiquitin-conjugating enzymes. | Nat Commun | 2023 | 37558718 | PubTator, text mining | PubMed |
| Identification and characterization of putative biomarkers and therapeutic axis in Glioblastoma multiforme microenvironment. | Front Cell Dev Biol | 2023 | 37538397 | PubTator, text mining | PubMed |
| Aggrephagy-related patterns in tumor microenvironment, prognosis, and immunotherapy for acute myeloid leukemia: a comprehensive single-cell RNA sequencing analysis. | Front Oncol | 2023 | 37534253 | PubTator, text mining | PubMed |
| Emerging roles of Aurora-A kinase in cancer therapy resistance. | Acta Pharm Sin B | 2023 | 37521867 | PubTator, text mining | PubMed |
| Oxidative Stress Markers and Heat Shock Proteins in Non-Obese Women with Polycystic Ovary Syndrome Are Not Elevated and Show No Correlation with Vitamin D. | Biomedicines | 2023 | 37509682 | PubTator, text mining | PubMed |
| Effects of DNA, RNA, and Protein Methylation on the Regulation of Ferroptosis. | Int J Biol Sci | 2023 | 37497000 | PubTator, text mining | PubMed |
| Blood transcriptome analysis in a buck-ewe hybrid points towards an nuclear factor-kappa B lymphoproliferative autoimmune disorder. | Sci Rep | 2023 | 37488170 | PubTator, text mining | PubMed |
| CAMK2D serves as a molecular scaffold for RNF8-MAD2 complex to induce mitotic checkpoint in glioma. | Cell Death Differ | 2023 | 37468549 | PubTator, text mining | PubMed |
| The Role of Nutraceuticals and Functional Foods in Skin Cancer: Mechanisms and Therapeutic Potential. | Foods | 2023 | 37444367 | PubTator, text mining | PubMed |
| A computational approach for the identification of key genes and biological pathways of chronic lung diseases: a systems biology approach. | BMC Med Genomics | 2023 | 37422662 | PubTator, text mining | PubMed |
| Gene SH3BGRL3 regulates acute myeloid leukemia progression through circRNA_0010984 based on competitive endogenous RNA mechanism. | Front Cell Dev Biol | 2023 | 37397256 | PubTator, text mining | PubMed |
| The central inflammatory regulator IκBζ: induction, regulation and physiological functions. | Front Immunol | 2023 | 37377955 | PubTator, text mining | PubMed |
| UBE2C expression is elevated in hepatoblastoma and correlates with inferior patient survival. | Front Genet | 2023 | 37377594 | PubTator, text mining | PubMed |
| Exosomes: A Promising Strategy for Repair, Regeneration and Treatment of Skin Disorders. | Cells | 2023 | 37371095 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7334/papers?page=8